961.16 Schedule II. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule II:
(2) Substances of plant origin. Any material, compound, mixture or preparation which contains any quantity of any of the following substances in any form, including a substance contained in a plant, obtained from a plant, chemically synthesized or obtained by a combination of extraction from a plant and chemical synthesis:
(a) Opium and substances derived from opium, and any salt, compound, derivative or preparation of opium or substances derived from opium. Apomorphine, dextrorphan, nalbuphine, butorphanol, naldemedine, nalmefene, naloxegol, naloxone, 6-beta-naltrexol, and naltrexone and their respective salts and the isoquinoline alkaloids of opium and their respective salts are excluded from this paragraph. The following substances, and any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation, are included in this paragraph:
1. Opium, including raw opium, opium extracts, opium fluid extracts, powdered opium, granulated opium and tincture of opium.
2. Opium poppy and poppy straw.
3. Concentrate of poppy straw, which is the crude extract of poppy straw in either liquid, solid or powder form containing the phenanthrene alkaloids of the opium poppy.
4. Codeine.
4m. Dihydrocodeine.
4r. Dihydroetorphine.
5. Ethylmorphine.
6. Etorphine hydrochloride.
7. Hydrocodone, also known as dihydrocodeinone.
8. Hydromorphone, also known as dihydromorphinone.
9. Metopon.
10. Morphine.
10m. Noroxymorphone.
11. Oxycodone.
12. Oxymorphone.
13. Thebaine.
(b) Coca leaves and any salt, compound, derivative or preparation of coca leaves. Decocainized coca leaves or extractions which do not contain cocaine or ecgonine are excluded from this paragraph. [123I]Ioflupane is excluded from this paragraph. The following substances and any of their salts, esters, isomers and salts of esters and isomers that are theoretically possible within the specific chemical designation, are included in this paragraph:
1. Cocaine.
2. Ecgonine.
(3) Synthetic opiates. Any material, compound, mixture or preparation which contains any quantity of any of the following synthetic opiates, including any of their isomers, esters, ethers, esters and ethers of isomers, salts and salts of isomers, esters, ethers and esters and ethers of isomers that are theoretically possible within the specific chemical designation:
(a) Alfentanil;
(am) Alphaprodine;
(b) Anileridine;
(c) Bezitramide;
(cm) Carfentanil;
(e) Diphenoxylate;
(f) Fentanyl;
(g) Isomethadone;
(gm) Levo-alphacetylmethadol (LAAM);
(h) Levomethorphan;
(j) Levorphanol;
(k) Meperidine, also known as pethidine;
(m) Meperidine — Intermediate — A, 4-cyano-1-methyl-4- phenylpiperidine;
(n) Meperidine — Intermediate — B, ethyl-4-phenylpiperidine- 4-carboxylate;
(p) Meperidine — Intermediate — C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
(q) Metazocine;
(r) Methadone;
(s) Methadone — Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenylbutane;
(t) Moramide — Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropanecarboxylic acid;
(ta) Oliceridine;
(tb) Oripavine;
(u) Phenazocine;
(v) Piminodine;
(w) Racemethorphan;
(x) Racemorphan;
(xm) Remifentanil;
(y) Sufentanil;
(zt) Tapentadol;
(zx) Thiafentanil.
(5) Stimulants. Any material, compound, mixture, or preparation which contains any quantity of any of the following substances having a stimulant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
(a) Amphetamine.
(b) Methamphetamine.
(c) Phenmetrazine.
(d) Methylphenidate.
(e) Lisdexamfetamine.
(7) Depressants. Any material, compound, mixture, or preparation which contains any quantity of any of the following substances having a depressant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
(a) Amobarbital;
(am) Glutethimide;
(b) Pentobarbital;
(c) Secobarbital.
(8) Immediate precursors. Any material, compound, mixture or preparation which contains any quantity of the following substances:
(a) An immediate precursor to amphetamine or methamphetamine:
1. Phenylacetone, commonly known as “P2P".
(b) An immediate precursor to fentanyl, including all of the following:
1. 4-anilino-N-phenethyl-4-piperidine, commonly known as ANPP.
2. N-phenyl-N-(piperidin-4-yl)propionamide, commonly known as norfentanyl.
(c) Immediate precursors to phencyclidine, also known as PCP:
1. 1-phenylcyclohexylamine.
2. 1-piperidinocyclohexanecarbonitrile.
(10) Hallucinogenic substances.
(a) Dronabinol [(-)-delta-9-trans-tetrahydrocannabinol (delta-9-THC)] in an oral solution in a drug product approved by the U.S. food and drug administration.
(b) Nabilone (another name for nabilone is (+)-trans-3-(1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1-hydroxy-6, 6-dimethyl-9H-dibenzo[b,d]pyran-9-one).
History: 1971 c. 219; 1981 c. 6, 206; 1989 a. 121; 1993 a. 98; 1995 a. 448 ss. 168 to 178, 473; Stats. 1995 s. 961.16; 2013 a. 351; 2015 a. 195 s. 83; 2017 a. 365 s. 111; ss. CSB 2.16, 2.17, 2.19, 2.21, 2.22, 2.25, 2.26, 2.35, 2.39, 2.40, 2.44, 2.54, 2.58, 2.69, 2.76, 2.80, 2.85, 2.90, Wis. adm. code.
NOTE: See 1979-80 stats. and 1993-94 stats. for notes on actions by the Controlled Substances Board under s. 161.11 (1), 1993 stats.
At a preliminary hearing, the state must show that a substance was probably l-cocaine rather than d-cocaine. State v. Russo, 101 Wis. 2d 206, 303 N.W.2d 846 (Ct. App. 1981).
Structure Wisconsin Statutes & Annotations
Wisconsin Statutes & Annotations
Chapter 961 - Uniform controlled substances act.
961.001 - Declaration of intent.
961.003 - Uniformity of interpretation.
961.11 - Authority to control.
961.115 - Native American Church exemption.
961.23 - Dispensing of schedule V substances.
961.235 - Records relating to sales of pseudoephedrine products.
961.24 - Publishing of updated schedules.
961.25 - Controlled substance analog treated as a schedule I substance.
961.32 - Possession authorization.
961.335 - Special use authorization.
961.337 - Drug disposal programs.
961.34 - Controlled substances therapeutic research.
961.37 - Law enforcement duty.
961.385 - Prescription drug monitoring program.
961.39 - Limitations on optometrists.
961.395 - Limitation on advanced practice nurses.
961.41 - Prohibited acts A — penalties.
961.42 - Prohibited acts B — penalties.
961.43 - Prohibited acts C — penalties.
961.44 - Penalties under other laws.
961.443 - Immunity from criminal prosecution; possession.
961.452 - Defenses in certain schedule V prosecutions.
961.453 - Purchases of pseudoephedrine products on behalf of another person.
961.455 - Using a child for illegal drug distribution or manufacturing purposes.
961.46 - Distribution to persons under age 18.
961.47 - Conditional discharge for possession or attempted possession as first offense.
961.472 - Assessment; certain possession or attempted possession offenses.
961.473 - Victim impact panels.
961.48 - Second or subsequent offenses.
961.495 - Possession or attempted possession of a controlled substance on or near certain places.
961.50 - Suspension or revocation of operating privilege.
961.51 - Powers of enforcement personnel.
961.52 - Administrative inspections and warrants.
961.53 - Violations constituting public nuisance.
961.54 - Cooperative arrangements and confidentiality.
961.555 - Forfeiture proceedings.
961.56 - Burden of proof; liabilities.
961.565 - Enforcement reports.
961.573 - Possession of drug paraphernalia.
961.574 - Manufacture or delivery of drug paraphernalia.
961.575 - Delivery of drug paraphernalia to a minor.
961.576 - Advertisement of drug paraphernalia.
961.577 - Municipal ordinances.
961.65 - Possessing materials for manufacturing methamphetamine.
961.67 - Possession and disposal of waste from manufacture of methamphetamine.
961.69 - Possession, use, manufacture, distribution, or advertisement of a masking agent.